Literature DB >> 16964551

Detection of cellular immunity to rabies antigens in human vaccinees.

Susan M Moore1, Melinda J Wilkerson, Rolan D Davis, Carol R Wyatt, Deborah J Briggs.   

Abstract

A nonradioactive multi-parameter flow cytometry assay was developed to identify antigen-specific lymphocytes in human subjects previously vaccinated against rabies virus and was subsequently compared to the standard tritiated thymidine method. A cell tracking dye, carboxyfluorescein succinimidyl ester, was used in combination with surface label for CD4 and CD8 cells in order to determine the response of lymphocytes to killed rabies virus in an antigen recall assay. The rabies virus-specific lymphocyte response was compared to the humoral immune response in each of ten vaccinated and five non-vaccinated subjects. Lymphocyte responses to rabies virus were observed in all ten vaccinated subjects; some noted as early as 3 days after stimulation while others were not until 7 days after stimulation. There was good agreement between the proliferation index of the CFSE assay and the simulation index of the [3H]thymidine assay (kappa statistic=0.73). An inverse relationship was detected between the level of rabies virus neutralizing antibody (RVNA) and the lymphocyte response to inactivated rabies virus in the vaccinated subjects. The association between cytokines production and level of humoral and cellular response was investigated in four representative subjects. Two vaccinated subjects with high proliferation indices and low RVNA titers produced Th1 type cytokines to rabies virus stimulation, whereas two vaccinated individuals with low proliferation indices and high RVNA titers responses did not produce these cytokines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16964551     DOI: 10.1007/s10875-006-9044-0

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  19 in total

1.  Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: validation of a new booster dose strategy.

Authors:  C Strady; R Jaussaud; I Béguinot; M Lienard; A Strady
Journal:  Vaccine       Date:  2000-06-01       Impact factor: 3.641

Review 2.  Immunopathology and immunoprotection in CNS virus infections: mechanisms of virus clearance from the CNS.

Authors:  D C Hooper; C Sauder; G S Scott; B Dietzschold; J A Richt
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

Review 3.  Memory T cells and vaccines.

Authors:  Mark T Esser; Rocio D Marchese; Lisa S Kierstead; Lynda G Tussey; Fubao Wang; Narendra Chirmule; Michael W Washabaugh
Journal:  Vaccine       Date:  2003-01-17       Impact factor: 3.641

Review 4.  Practical significance of rabies antibodies in cats and dogs.

Authors:  M F Aubert
Journal:  Rev Sci Tech       Date:  1992-09       Impact factor: 1.181

Review 5.  The role of immune responses in the pathogenesis of rabies.

Authors:  D Craig Hooper
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

6.  Sexist diseases.

Authors:  M Garenne; M Lafon
Journal:  Perspect Biol Med       Date:  1998       Impact factor: 1.416

7.  Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory.

Authors:  D Fulcher; S Wong
Journal:  Immunol Cell Biol       Date:  1999-12       Impact factor: 5.126

8.  Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man.

Authors:  O Thraenhart; E Kreuzfelder; M Hillebrandt; I Marcus; K Ramakrishnan; Z F Fu; B Dietzschold
Journal:  Clin Immunol Immunopathol       Date:  1994-06

9.  Human rabies prevention--United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1999-01-08

10.  Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system.

Authors:  D C Hooper; K Morimoto; M Bette; E Weihe; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

View more
  12 in total

Review 1.  Experimental rabies vaccines for humans.

Authors:  James P McGettigan
Journal:  Expert Rev Vaccines       Date:  2010-10       Impact factor: 5.217

Review 2.  Deciphering serology to understand the ecology of infectious diseases in wildlife.

Authors:  Amy T Gilbert; A R Fooks; D T S Hayman; D L Horton; T Müller; R Plowright; A J Peel; R Bowen; J L N Wood; J Mills; A A Cunningham; C E Rupprecht
Journal:  Ecohealth       Date:  2013-08-06       Impact factor: 3.184

3.  A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.

Authors:  Ralf Amann; Jörg Rohde; Ulrich Wulle; Douglas Conlee; Rudiger Raue; Olivier Martinon; Hanns-Joachim Rziha
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

4.  TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).

Authors:  Asha Jayakumar; Tiago M Castilho; Esther Park; Karen Goldsmith-Pestana; Jenefer M Blackwell; Diane McMahon-Pratt
Journal:  PLoS Negl Trop Dis       Date:  2011-06-14

5.  Loss of multi-epitope specificity in memory CD4(+) T cell responses to B. pertussis with age.

Authors:  Wanda G H Han; Inonge van Twillert; Martien C M Poelen; Kina Helm; Jan van de Kassteele; Theo J M Verheij; Florens G A Versteegh; Claire J P Boog; Cécile A C M van Els
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

6.  Changes in cellular proliferation and plasma products are associated with liver failure.

Authors:  Juliana Gil Melgaço; Frederico Marianetti Soriani; Pedro Henrique Ferreira Sucupira; Leonardo Assaf Pinheiro; Yasmine Rangel Vieira; Jaqueline Mendes de Oliveira; Lia Laura Lewis-Ximenez; Cristina Carvalho Vianna Araújo; Lúcio Filgueiras Pacheco-Moreira; Gustavo Batista Menezes; Oswaldo Gonçalves Cruz; Claudia Lamarca Vitral; Marcelo Alves Pinto
Journal:  World J Hepatol       Date:  2016-11-18

Review 7.  The Cellular Immune Response to Rabies Vaccination: A Systematic Review.

Authors:  Lisanne A Overduin; Jacques J M van Dongen; Leonardus G Visser
Journal:  Vaccines (Basel)       Date:  2019-09-11

8.  Evidence of rabies virus exposure among humans in the Peruvian Amazon.

Authors:  Amy T Gilbert; Brett W Petersen; Sergio Recuenco; Michael Niezgoda; Jorge Gómez; V Alberto Laguna-Torres; Charles Rupprecht
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

9.  Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2.

Authors:  Tiina Nokireki; Miia Jakava-Viljanen; Anna-Maija Virtala; Liisa Sihvonen
Journal:  Acta Vet Scand       Date:  2017-10-02       Impact factor: 1.695

10.  Rabies Virus Antibodies from Oral Vaccination as a Correlate of Protection against Lethal Infection in Wildlife.

Authors:  Susan M Moore; Amy Gilbert; Ad Vos; Conrad M Freuling; Christine Ellis; Jeannette Kliemt; Thomas Müller
Journal:  Trop Med Infect Dis       Date:  2017-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.